ArticleJournal of Cancer2025

Integrative multi-omics and machine learning identify a robust signature for discriminating prognosis and therapeutic targets in bladder cancer.

Zhiyong Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.